Fiche personne


Territoire

Alsace

Statut

Post-doctorant

Publications


Targeting peroxiredoxin 2 prevents hepatocarcinogenesis in metabolic liver disease.

Crouchet E, Schaeffer E, Oudot MA, Moehlin J, Gadenne C, Jühling F, El Saghire H, Fujiwara N, Zhu S, Akter Rasha F, Durand SC, Charlot A, Ponsolles C, Martin R, Brignon N, Del Zompo F, Meiss Heydmann L, Parnot M, Hamdane N, Heide D, Hetzer J, Heikenwälder M, Felli E, Pessaux P, Pochet N, Zoll J, Cunniff B, Hoshida Y, Mailly L, Baumert TF, Schuster C

J Clin Invest. 2025 09 11;:

Claudin-1 is a mediator and therapeutic target in primary sclerosing cholangitis.

Del Zompo F, Crouchet E, Ostyn T, Nehme Z, Messé M, Juehling F, Désert R, Vieira AT, Moehlin J, Nakib D, Andrews T, Perciani C, Chung S, Bader G, McGilvray I, Caime C, Scaravaglio M, Carbone M, Invernizzi P, Yaqub S, Folseraas T, Karlsen TH, Shankar G, Primeaux M, Dhawan P, Banales JM, Roehlen N, Iacone R, Teixeira G, Heikenwälder M, Mailly L, MacParland S, Roskams T, Govaere O, Schuster C, Baumert TF

J Hepatol. 2025 08 20;:

[The circadian clock: a new therapeutic target for liver fibrosis].

Crouchet É, Schuster C, Baumert TF

Med Sci (Paris). 2025 04;41(4):312-315

Voir plus